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We evaluated the sensitivity of a DNA amplification test for the detection of Mycobacterium avium in blood
samples using different blood components and different DNA extraction methods. M. avium-inoculated blood
samples were processed to obtain separate blood components: peripheral blood mononuclear cells (PBMCs),
polymorphonuclear cells (PMNCs), and whole-blood sodium dodecyl sulfate (SDS)-lysate pellets. The sensi-
tivity for the detection of the lowest mycobacterial load (1 CFU/ml) was significantly greater (P < 0.01) with
DNA extracted from SDS-lysate pellets than with DNA extracted from PBMCs or PMNCs. Subsequently, DNA
extraction methods based on guanidine NaOH, and proteinase were compared. The sensitivity of the guani-
dine-based method was significantly greater (P < 0.01) than those of the others.
In the last 2 decades, the impact of the AIDS epidemic and
the diffusion of immunosuppressive conditions have resulted in
a substantial increase in the incidence of disseminated Myco-
bacterium avium complex (MAC) infections (5, 8, 13, 14, 21,
22, 31). The diagnosis of disseminated MAC infection is often
based on suggestive clinical signs and symptoms (2, 5, 11, 16),
but in only 12% of the cases it is confirmed by a positive blood
culture (6). The culture of mycobacteria from blood takes from
2 to 4 weeks after the culture inoculation (1, 2, 16); thus, there
is a considerable need to develop more-rapid diagnostic tests
on blood samples. Several studies proposing different amplifi-
cation protocols have been published so far (4, 7, 9, 16, 17, 20,
29), but the standardization of a reliable amplification method
for disseminated MAC infection diagnosis has not been
achieved yet. The aim of this study was to analyze the sensi-
tivity of a PCR-based method for the detection of M. avium in
blood samples by using on different blood components or dif-
ferent DNA extraction methods.
First, we evaluated the performance of the assay by using
different blood components (experiment A). Fifty milliliters of
peripheral blood was drawn from a healthy donor (sodium
citrate at 3.8% was the anticoagulant) and divided into five
parts (10 ml each); four parts were inoculated in vitro with four
different M. avium bacterial loads (300, 30, 3, and 1 CFU/ml),
and the remaining part was utilized as a negative control (Fig.
1A).
For blood sample inoculation, an M. avium isotonic saline
suspension was prepared from a clinical isolate identified as M.
avium by standard microbiological and biochemical tests (18).
The isolate was grown at 35°C and 5% CO2 on Lowenstein-
Jensen medium supplemented with 10% oleic acid-albumin-
dextrose-catalase (OADC) enrichment medium (Becton Dick-
inson, Rutherford, N.J.). The suspension was homogenized
and sonicated in a sonicating water bath (50-Hz Cole-Parmer
sonicator) for 3 min at room temperature. The mycobacterial
concentration was determined on the basis of optical density
(OD) and adjusted to 3 3 107 mycobacteria/ml. The suspen-
sion was serially diluted (1:103, 1:104, 1:105, and 0.33:105), and
four isotonic saline volumes (10 ml each) were inoculated with
100 ml of the dilutions. Triplicate 100-ml samples of the inoc-
ulated isotonic saline volumes were plated on agar medium
(Middlebrook 7H10 plus 10% OADC; Becton Dickinson), and
the colonies were counted after 14 and 28 days of incubation at
37°C. The concentrations of the isotonic saline volumes were
300 (coefficient of variation, 610%), 30 (coefficient of varia-
tion, 610%), 3 (coefficient of variation, 65%), and 1 CFU/ml
(coefficient of variation, 67%), respectively (coefficients of
variation refer to mycobacterial CFU counts of three controls
per concentration). The serial dilutions of the mycobacterial
suspension were utilized to inoculate blood samples (100 ml of
dilutions/10 ml of blood in experiment A and 250 ml of dilu-
tions/25 ml of blood in experiment B). Inoculated blood sam-
ples were incubated at 37°C and 5% CO2 for 1 h on a rotator
to allow phagocytosis and then subdivided in aliquots of 5 ml
each. The range of bacterial load of inoculated blood samples
corresponds to bacterial titers in disseminated MAC infections
in the majority of patients at the time of diagnosis (from 1 to
300 CFU/ml) (6, 12, 15, 20).
The 5-ml aliquots underwent two different pretreatments to
obtain three separate blood components. (i) Gradient separa-
tion by Mono-Poly resolving medium (M-PRM; density coef-
ficient, 1.114 6 0.002; Flow Laboratories Inc., McLean, Va.)
was used to collect peripheral blood mononuclear cells (PBMCs)
and polymorphonuclear cells (PMNCs) according to the man-
ufacturer’s instructions (upper layers of plasma and red blood
cell pellets were also separately collected). (ii) Lysis by sodium
dodecyl sulfate (SDS) (final concentration, 1%) and subse-
quent centrifugation (4,000 3 g at 5°C for 30 min) was used to
obtain lysate-blood pellets, as previously described (10) (su-
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FIG. 1. (A) Whole peripheral blood (50 ml) was divided into five parts (10 ml each). Four parts were inoculated in vitro with four different M.
avium bacterial loads (300, 30, 3, and 1 CFU/ml), and the remaining part was utilized as a negative control. Each part was further subdivided to
obtain two aliquots (5 ml each). These aliquots underwent one of two different pretreatments (lysis by SDS or cell separation by gradient
centrifugation) to obtain three separate blood components: SDS-lysate pellet, PBMCs, and PMNCs. The guanidine-based method was used for
DNA extraction. PCR amplification was performed with 1 mg of DNA per replicate, and eight replicates were amplified for each DNA sample.
a, the presence of M. avium in SDS-lysate supernatants, plasma layers, and red blood cell pellets (RBCP) (after M-PRM separation) from
300-CFU/ml blood samples was also investigated; PCR analysis was performed for the totality of DNA extracted from these components. (B)
Whole peripheral blood (125 ml) was divided into five parts (25 ml each). Four parts were inoculated in vitro with four different M. avium bacterial
loads, and the remaining part was utilized as a negative control. Each part was further subdivided to obtain five aliquots (5 ml each). These aliquots
underwent pretreatment with SDS. Three DNA extraction methods (guanidine-based method, NaOH-based method with or without purification,
and PK-based method with or without purification) were used for DNA extraction. PCR amplification was performed with 1 mg of DNA per
replicate, and eight replicates were amplified for each DNA sample. PCI, phenol-chloroform-isoamylalcohol.
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pernatants were also collected). DNA extraction was per-
formed using a guanidine-based method (Easy-DNA kit; In-
vitrogen BV, Leek, The Netherlands) according to the
manufacturer’s instructions; OD was used to determine the
DNA concentration. The concentrations of extracted DNA
from PBMCs, PMNCs, and SDS-lysate pellets were normal-
ized at 100 ng/ml by adding nuclease-free H2O. Each DNA
sample was amplified by utilizing 1 mg of DNA per PCR
replicate and performing eight PCR replications per sample (a
total of 8 mg of DNA per sample underwent PCR amplifica-
tion) (Fig. 1A). Amplification and a hybridization assay were
performed to identify the M. avium target sequence according
to a previously described protocol (3, 23, 24). The PCR-hy-
bridization colorimetric reaction was read at 450 nm using a
spectrophotometer to determine positive and negative repli-
cates: OD values higher than 0.4 were considered positive (24).
DNA samples were amplified for the b-globin gene sequence
to assess the presence of PCR inhibitors and the integrity of
the template DNA (25). Each PCR-hybridization run was per-
formed using positive (10 fg of DNA from M. avium ATCC
15769) and negative (human DNA and nuclease-free H2O)
controls and sterilization procedures in accordance with guide-
lines for maintaining contamination-free conditions to prevent
false-positive results (19). PCR-hybridization analysis was also
performed on the totality of DNA (extracted by the guanidine
method) from SDS-lysate supernatants of 300-CFU/ml blood
samples and from plasma layers and red blood cell pellets
which were collected after M-PRM separation of 300-CFU/ml
blood samples. After evaluation of the pretreatment methods,
three DNA extraction methods were compared (experiment
B). Five 25-ml aliquots of peripheral blood, inoculated with M.
avium, were obtained as described above. Each part was fur-
ther subdivided to obtain five aliquots (5 ml each). These
aliquots underwent pretreatment with SDS to obtain SDS-
lysate pellets. Three DNA extraction methods were used: (i) a
guanidine-based method as described above; (ii) an NaOH-
based method as previously described (20), with or without
DNA purification by a phenol-chloroform-isoamyl alcohol
(PCI) protocol (27); and (iii) a proteinase K (PK)-based
method as previously described (30), with or without PCI DNA
purification (Fig. 1B). OD was used to determine DNA con-
centration.
Both experiments A and B were repeated three times in
three separate sessions to evaluate the reproducibility of tests.
The proportions of positive replicates of the eight-PCR-repli-
cate set of three separate experiments were calculated, and the
sensitivity of each single replicate was calculated. Student’s
unpaired t test was used to compare the proportions of positive
replicates.
M. avium PCR-hybridization analysis performed on DNA
from PBMCs, PMNCs, and SDS-lysate pellets of noninocu-
lated blood aliquots was negative for all 72 PCR replicates,
while b-globin gene PCR yielded 100% positive replicates,
ruling out PCR inhibitors or lack of DNA integrity.
The results of PCR-hybridization analysis on DNA extracted
from PBMCs showed that the M. avium target sequence was
detectable on 300-, 30-, and 3-CFU/ml samples; the sensitivi-
ties of single PCR replicates were 41, 20, and 8%, respectively
(Table 1). PCR-hybridization results for DNA extracted from
PMNCs showed an increased sensitivity of single PCR repli-
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cates in 300- and 30-CFU/ml samples (62 and 45%, respec-
tively) compared to the sensitivity of those in PBMC samples;
the same sensitivity was evident from 3-CFU/ml samples (8%).
PCR-hybridization analysis failed to detect the target sequence
from samples with the lowest bacterial load (1 CFU/ml) in
DNA extracted from both PMNCs and PBMCs in three sep-
arate experiments.
As regards the data obtained by DNA extracted from SDS-
lysate pellets, the sensitivity of single PCR replicates was sig-
nificantly greater (P , 0.01) than the sensitivities of replicates
in PMNC and PBMC samples (87% for 300 CFU/ml, 50% for
30 CFU/ml, 50% for 3 CFU/ml, and 20% for 1 CFU/ml) and
the PCR-hybridization assay detected the target sequence even
from samples with the lowest bacterial load (1 CFU/ml).
No target DNA sequence was detectable in SDS-lysate su-
pernatants of 300-CFU/ml blood samples, thus showing that
M. avium DNA was absent from or present in small amounts in
SDS-lysate supernatants. Similarly, PCR analysis was per-
formed on DNA from plasma layers and red blood cell pellets
which were collected after M-PRM separation of 300-CFU/ml
blood samples, and no target sequence was detectable. Thus,
we assumed that all mycobacteria were adherent to blood
leukocytes or phagocytosed by monocytes or PMNCs. The
b-globin gene PCR control showed that no inhibitors were
present in any of the DNA samples tested.
Subsequently, the comparison of the sensitivities of the three
different DNA extraction methods analyzed showed that the
NaOH-based method allowed for the detection of M. avium
DNA in samples with concentrations as low as 3 CFU/ml, with
single-replicate sensitivities of 8% when PCI-purified DNA
was analyzed and 4% when not-purified DNA was analyzed
(Table 2). PK extraction allowed target detection solely in
300-CFU/ml samples, with single-replicate sensitivity of 16%
for PCI-purified DNA; target detection failed in 30-, 3-, and
1-CFU/ml samples. Both NaOH-based and PK-based methods
showed sensitivities significantly lower than that for the guani-
dine-based DNA extraction technique (P , 0.01), which
yielded a positive detection even at the lowest bacterial load
(1-CFU/ml samples), with single-replicate sensitivity of 20%,
in three separate experiments (Table 2).
Several PCR-based methods for the diagnosis of MAC bac-
teremia are described in the literature, and different authors
report sensitivities ranging from 56 to 100% (4, 7, 9, 16, 17, 20,
29). The sensitivity depends on different factors: volume of
sample and number of organisms per milliliter of blood, pro-
cedures for the treatment of blood samples, extraction meth-
ods, total amount of DNA utilized for PCR analysis, and the
PCR assay detection limit. Furthermore, when applied to
DNA extracted from blood samples, PCR amplification is fre-
quently hampered by the presence of inhibitors, and false-
positive results, due to contamination, may reduce the useful-
ness of PCR methods in routine diagnosis.
We tested different pretreatment techniques to evaluate the
blood component-related sensitivity of the PCR assay. Indeed,
the sensitivity was apparently related to the analyzed blood
components. Our results showed a significantly greater sensi-
tivity (P , 0.01) for the PCR assay when it was done on DNA
extracted from SDS-lysate pellets. This result could be ex-
plained by the specimen preparation procedures. We could
lyse most of the human cells by SDS, preserving the integrity of
mycobacteria, given the resistance of the mycobacterial cell
wall (10, 25, 26, 29). Compared to the other pretreatment
methods, this technique allowed an increase in the mycobac-
terial DNA/total DNA ratio of about 5- to 10-fold, with a
consequent proportional rise in the probability of detecting
target DNA. For this purpose, SDS-lysate pellet preparation
was highly efficient, as demonstrated by a PCR-hybridization
assay done on SDS-lysate supernatants that showed the ab-
sence of M. avium DNA in this component. Moreover, the
recovery of PMNCs and PBMCs (either by M-PRM or Ficoll-
Hypaque) is less than 100% efficient; this inefficiency could be
correlated with the lower sensitivities of these methods.
The better sensitivity of guanidine-based DNA extraction
could be explained by the finding that the method using gua-
nidine isothiocyanate has a greater ability than the other meth-
ods to lyse mycobacterial cell walls.
In conclusion, our study shows that the sensitivity of the
PCR method for detection of M. avium in blood samples de-
pends on the pretreatment extraction methods utilized and
strictly correlates to the DNA extraction techniques per-
formed.
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